Climb Bio (CLYM) Earnings Analysis
Climb Bio (CLYM) has no confirmed upcoming earnings date. Last quarter (2026-05-07) it beat with EPS -0.2 USD vs -0.26 USD est (+23.1%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -16.13.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLYM next report earnings?
No confirmed upcoming earnings date is currently scheduled for CLYM. This page updates as the calendar is published.
CLYM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.2 USD | -0.26 USD | +23.1% | Beat |
| 2026-03-05 | -0.26 USD | -0.2 USD | -30% | Miss |
| 2025-11-06 | -0.19 USD | -0.16 USD | -18.8% | Miss |
| 2024-08-14 | -1.81 USD | n/a | n/a | n/a |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
CLYM valuation and analyst view
| Trailing P/E | -16.13 |
|---|---|
| Trailing EPS | -0.77399 USD |
| Price / book | 5.79 |
| Dividend yield | 0.00% |
| Market cap | 0.85B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 22.5 USD |
Related research pages
Frequently asked questions
When is Climb Bio (CLYM)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CLYM. This page updates as the calendar is published.
Did CLYM beat earnings last quarter?
In its 2026-05-07 report, CLYM posted EPS of -0.2 USD versus a -0.26 USD estimate — a beat of 23.1%.
What is CLYM's earnings track record?
Over the last 3 reported quarters with consensus data, CLYM beat estimates 1 times (33%).
What is CLYM's current P/E ratio and EPS?
CLYM trades at a trailing P/E of -16.13 on trailing EPS of -0.7739932520139006 USD.
What do analysts rate CLYM?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 22.5 USD.